SCHEMBL31716530

SCHEMBL31716530

Fc1ccc2c(c1)[nH]c1cc(Br)ccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 1/20 0.50
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ FEN1 P39748 1/20 0.47
▸ CCNB2 O95067 1/20 0.45
▸ CDK1 P06493 1/20 0.45
▸ CCNB1 P14635 1/20 0.45
▸ CCNA2 P20248 1/20 0.45
▸ CDK2 P24941 1/20 0.45
▸ CCNA1 P78396 1/20 0.45
▸ CDK5 Q00535 1/20 0.45
▸ CDK5R1 Q15078 1/20 0.45
▸ CCNB3 Q8WWL7 1/20 0.45
▸ METAP2 P50579 1/20 0.42
▸ DAO P14920 1/20 0.42
▸ PIM3 Q86V86 1/20 0.41
▸ PDPK1 O15530 1/20 0.41
▸ JAK2 O60674 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30227407 0.90 KIF11 (0.64) KIF11MEN1KMT2AFEN1METAP2
SCHEMBL1517851 0.87 KIF11 (0.61) KIF11MEN1KMT2AFEN1CCNB2
SCHEMBL29507671 0.87 KIF11 (0.61) KIF11MEN1KMT2AFEN1CCNB2
SCHEMBL29397381 0.87 METAP2 (0.52) CCNB2CDK1CCNB1CCNA2CDK2
SCHEMBL181890 0.87 METAP2 (0.52) CCNB2CDK1CCNB1CCNA2CDK2
SCHEMBL28272924 0.87 METAP2 (0.52) CCNB2CDK1CCNB1CCNA2CDK2
Ethane SCHEMBL29122859 0.82 METAP2 (0.48) KIF11CCNB2CDK1CCNB1CDK5
SCHEMBL10050070 0.80 CHUK (0.48) CCNB2CDK1CCNB1CCNA2CDK2
SCHEMBL6980120 0.79 ACHE (0.55) KIF11MEN1KMT2AFEN1CDK5
SCHEMBL15380304 0.78 KIF11 (0.75) KIF11MEN1KMT2AFEN1CCNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025227032-A1 METHODS FOR DEGRADATION OF CYCLIN K AND INHIBITION OF CYCLIN DEPENDENT KINASES REMIX THERAPEUTICS INC. (US) 2025-10-30 — — WO disclosed
Send feedback